Care workers with the Service Employees International Union (SEIU) participate in a living cemetery ... More protest at the US Capitol June 23, 2025 in Washington, DC. Workers denounced the impact to patients, families and workers if Republicans cut Medicaid, healthcare and SNAP to pay for tax cuts for the wealthy. (Photo by Tasos Katopodis/Getty Images for SEIU)Getty Images for SEIUNews government-subsidized health insurance provider Centene is withdrawing its 2025 financial guidance comes as the Republica ...

SHENZHEN, China, July 02, 2025 (GLOBE NEWSWIRE) -- According to Euromonitor International’s 2025 research, K&F CONCEPT, a leading photography accessories brand, has secured its position as the No.1 filter brand among camera accessory brands worldwide. Unrivaled Market LeadershipThrough sustained investment in product innovation and global market expansion, K&F CONCEPT is rapidly emerging as a leading brand in the photography accessories industry. With operations in over 120 countries and annual revenue exce ...

It's been a turbulent time for Archer-Daniels-Midland (NYSE: ADM ). In the first half of 2025 , the agribusiness giant was battered by thin soybean margins, policy confusion around renewable fuels and the return of tariffs on keyI'm a passionate investor from the Netherlands with 12 years of stock market experience. My articles usually contain a good overview of important investment criteria. A stock for my portfolio is of interest to me if the company has the following characteristics:1. Companies that are ...

Meta (NASDAQ: META ) shares are up more than 15.21% in the last month and are up nearly 25% year-to-date. I believe shares of Meta remain a buy given its bold, large-scale AI investments. Over the lastThis account is managed by Noah's Arc Capital Management. Our goal is provide Wall Street level insights to main street investors. Our research focus is mainly on 20th century stocks (old economy) undergoing a 21st century transformation, but occasionally we'll write on companies that help transform 20th centu ...

Chinese electric car company Xpeng displays its mass-market Mona M03 coupe inside a headquarters' showroom in Guangzhou, China, on Aug. 26, 2024.CNBC | Evelyn ChengBEIJING — Chinese electric car startup Xpeng is keeping up the sales momentum against its rivals, even as BYD expands on its market dominance amid a fierce price war in China.Xpeng said Tuesday it delivered 34,611 cars in June, its eighth-straight month of delivering more than 30,000 cars.Shares rose more than 2% in New York trading. Xpeng did no ...

Core Points - EQV Ventures Acquisition Corp. II announced the pricing of its initial public offering (IPO) of 42,000,000 units at a price of $10.00 per unit, increased from an initial plan of 35,000,000 units [1] - The units will be listed on the New York Stock Exchange under the ticker symbol "EVACU" and will begin trading on July 2, 2025 [1] - Each unit consists of one Class A ordinary share and one-third of a redeemable warrant, with the whole warrant allowing the purchase of one Class A ordinary share at $11.50 per share [1] - BTIG, LLC is the sole book-running manager for the offering, which is expected to close on July 3, 2025, subject to customary closing conditions [2] Additional Details - The underwriter has a 45-day option to purchase up to an additional 6,300,000 units at the IPO price to cover over-allotments [2] - The offering is being made only by means of a prospectus, with copies available from BTIG, LLC [3] - Registration statements for these securities have been filed with the U.S. Securities and Exchange Commission and became effective on July 1, 2025 [3]

Company Overview - Raytech Holding Limited is a Hong Kong-headquartered company specializing in the design, sourcing, and wholesale of personal care electrical appliances for international brand owners [5] - The company has over 10 years of experience in the personal care electrical appliance industry, offering a diverse range of products including hair styling tools, trimmers, eyelash curlers, neck care, and nail care appliances [5] Public Offering Details - The company announced the closing of its public offering of 25,985,000 ordinary shares at a public offering price of $0.20 per share on July 1, 2025 [1] - Gross proceeds from the offering are expected to be approximately $5.197 million before deducting placement agent fees and other expenses [2] - R.F. Lafferty & Co., Inc. acted as the sole placement agent for the offering [2] Regulatory Information - The securities were offered pursuant to a registration statement on Form F-1, which was declared effective by the U.S. Securities and Exchange Commission (SEC) on June 30, 2025 [3] - A preliminary prospectus related to the offering has been filed with the SEC, and copies of the final prospectus will be available from the placement agent [3]

Core Viewpoint - ArriVent BioPharma, Inc. has announced a public offering of common stock and pre-funded warrants, aiming to raise approximately $75 million to support its drug development programs and general corporate purposes [1][3]. Group 1: Offering Details - The public offering consists of 2,482,692 shares priced at $19.50 each and pre-funded warrants for 1,363,469 shares priced at $19.4999 each, with gross proceeds expected to be around $75 million before expenses [1]. - Underwriters have a 30-day option to purchase an additional 576,923 shares under the same terms [1]. - The offering is expected to close on or about July 3, 2025, pending customary closing conditions [2]. Group 2: Use of Proceeds - The net proceeds from the offering will be utilized to support the development of firmonertinib and other pipeline programs, as well as for working capital and general corporate purposes [3]. Group 3: Company Background - ArriVent is a clinical-stage biopharmaceutical company focused on developing innovative therapies to meet unmet medical needs in cancer treatment [6]. - The company aims to leverage its team's extensive drug development experience to advance its lead candidate, firmonertinib, and a pipeline of novel therapeutics [6].

Core Viewpoint - Hims & Hers Health, Inc. is facing securities class action lawsuits due to allegations of failing to disclose material information during the class period, which has resulted in significant financial losses for investors [3][4]. Group 1: Legal Actions - Investors have until August 25, 2025, to file lead plaintiff applications in the ongoing securities class action lawsuits against Hims & Hers Health, Inc. for purchases made between April 29, 2025, and June 23, 2025 [1][2]. - The lawsuits are pending in the United States District Court for the Northern District of California, with the first case filed being Sookdeo v. Hims & Hers Health, Inc. [5]. Group 2: Company Issues - Novo Nordisk terminated its partnership with Hims on June 23, 2025, citing violations of laws regarding the sale of compounded drugs and concerns over patient safety due to deceptive marketing practices [4]. - Following the announcement of the partnership termination, Hims' share price dropped by $22.24, or 34.6%, closing at $41.98 per share on June 23, 2025, amid unusually high trading volume [4]. Group 3: Law Firm Background - Kahn Swick & Foti, LLC, the law firm handling the lawsuits, is recognized as one of the top boutique securities litigation firms in the U.S., serving both institutional and retail investors [5].

Core Viewpoint - Compass Diversified Holdings is facing securities class action lawsuits due to alleged failure to disclose material information during the class period from March 1, 2023, to May 7, 2025, which has resulted in significant financial losses for investors [1][3]. Group 1: Legal Actions - Investors have until July 8, 2025, to file lead plaintiff applications in the ongoing class action lawsuits against Compass Diversified Holdings [1][2]. - The lawsuits are based on claims that Compass and its executives violated federal securities laws by not disclosing critical information during the specified class period [3]. Group 2: Company Disclosure and Impact - On May 7, 2025, Compass disclosed that its financial statements for fiscal 2024 would require restatement due to an ongoing internal investigation into its subsidiary, Lugano Holding, Inc. [4]. - The investigation revealed irregularities in Lugano's financing, accounting, and inventory practices, leading to the resignation of Lugano's founder and CEO, Moti Ferder [4]. - Following this announcement, Compass' share price dropped approximately 62%, from $17.25 to $6.55 per share within a day [4]. Group 3: Firm Background - Kahn Swick & Foti, LLC is a prominent securities litigation law firm involved in representing investors in cases of corporate fraud and malfeasance [5]. - The firm has been recognized among the top 10 firms nationally based on total settlement value [5].